Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.345 USD | +4.28% | +5.09% | +35.88% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/16/01 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/16/01 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/94/03 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/17/28 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01/07/01 |
Timothy Wright
BRD | Director/Board Member | 66 | 23/22/23 |
Jennifer Buell
BRD | Director/Board Member | 50 | 18/20/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.88% | 59.66L | |
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- PTIX Stock
- Company Protagenic Therapeutics, Inc.